Home / Market Reports / Medical Care
/ Global Point-of-Care Genetic Testing Market Growth (Status and Outlook) 2024-2030
Global Point-of-Care Genetic Testing Market Growth (Status and Outlook) 2024-2030
-
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to our LPI (LP Information) latest study, the global Point-of-Care Genetic Testing market size was valued at US$ 6166.7 million in 2023. With growing demand in downstream market, the Point-of-Care Genetic Testing is forecast to a readjusted size of US$ 7445.4 million by 2030 with a CAGR of 2.7% during review period.
The research report highlights the growth potential of the global Point-of-Care Genetic Testing market. Point-of-Care Genetic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point-of-Care Genetic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point-of-Care Genetic Testing market.
Point-of-care genetic testing identifies variations in the genetic sequence at the bedside – enabling clinicians to react and alter therapy based upon the results.
Key Features:
The report on Point-of-Care Genetic Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Point-of-Care Genetic Testing market. It may include historical data, market segmentation by Type (e.g., POCT Cancer Kits, Molecular POC Kits), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point-of-Care Genetic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Point-of-Care Genetic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Point-of-Care Genetic Testing industry. This include advancements in Point-of-Care Genetic Testing technology, Point-of-Care Genetic Testing new entrants, Point-of-Care Genetic Testing new investment, and other innovations that are shaping the future of Point-of-Care Genetic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point-of-Care Genetic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Point-of-Care Genetic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point-of-Care Genetic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point-of-Care Genetic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point-of-Care Genetic Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point-of-Care Genetic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point-of-Care Genetic Testing market.
Market Segmentation:
Point-of-Care Genetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
Segmentation by application
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)
RELATED REPORTS
- 17
Feb
2021
According to this latest study, the 2021 growth of Point-of-Care Genetic Testing will have significant change from previous year. By the most conservative estimates of global Point-of-Care Genetic Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Point-of-Care Genetic Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
$3660.00
